(Eagle News) — The Food and Drug Administration has permanently revoked the certificate of product registration of the controversial vaccine Dengvaxia. The FDA made the announcement in a statement after Sanofi Pasteur, the drug manufacturer, admitted the vaccine could cause severe dengue in those who were administered the same and who have not had dengue beforehand. Prior to Sanofi’s admission, over 800,000 schoolchildren were administered Dengvaxia under the government’s national immunization program launched during the […]